ANIKA THERAPEUTICS (NASDAQ:ANIK)
8.12
0.03 (0.37%)
| ANIKA THERAPEUTICS (NASDAQ:ANIK) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $8.15 | 52 Week High | $8.80 | ||
| Open | $8.15 | 52 Week Low | $2.96 | ||
| Day High | $8.27 | P/E | 22.56 | ||
| Day Low | $8.11 | EPS | $0.36 | ||
| Volume | 18,240 | ||||
| More ANIK Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| RSYS | 2 | KWR | 2 |
| GMR | 2 | ILMN | 2 |
| PSYS | 2 | QTM | 2 |
| USNA | 2 | ANAD | 2 |
| HRS | 2 | APOL | 2 |
| WSII | 2 | CQB | 2 |
Entities who have mentioned ANIK
- Merriman Curhan Ford | View Related Stories »
- Bankruptcy | View Related Stories »
- Scopia Capital | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Consumer Confidence Index | View Related Stories »
- Trading Radar | View Related Stories »
- Needham & Co | View Related Stories »
- Soleil Securities | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- S3 | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- Citi | View Related Stories »
- Dividend | View Related Stories »
View All Major News StreetInsider.com Major News for ANIK
- Anika Therapeutics (ANIK) Tops Q3 EPS by 3c
- Anika Therapeutics (ANIK) Reports In-Line Q2 EPS of $0.08
- Anika Therapeutics (ANIK) Misses Street's Q1 Views
View All ReportsStreetInsider.com Reports on ANIK
- Anika Therapeutics (ANIK) Received European CE Mark for Aesthetic 'ELEVESS Light'
- Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower
- Anika Therapeutics (ANIK) Tops Q3 EPS by 3c
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- Unusual 11 Mid-Day Movers 8/20: ANIK, AIG, FRZ, BONT Higher; CERS, AVII, STSA, QUIX Lower
View All Press ReleasesCompany Press Releases on ANIK
- Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
- Anika Therapeutics Reports 17% Revenue Growth in Third-Quarter 2009
- Anika Therapeutics Announces Date of Third Quarter 2009 Financial Results Conference Call
StreetInsider Reports on ANIK by Category
View All BlogsBlogs on ANIK
- Anika Therapeutics Inc. Q3 2009 Earnings Call Transcript
- Anika Therapeutics, Inc. Q2 2009 Earnings Call Transcript
- Anika Therapeutics Inc., Q4 2008 Earnings Conference Call
- Anika Therapeutics: Building On Previous Success
Comments on recent ANIK articles
Comments on ANIK
No comments are currently available.
on Oct 28, 2009
at 05:29 PM ANDREW OLIVER SATCHELL GOOD
Article: Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
on Apr 24, 2009
at 12:12 PM Unique Product Distributor This Product for Men or Women in one month stop losing and Start re-growing hair Garanteed. www.hairdreamcorp.com
Article: Anika Therapeutics (ANIK) Terminates US Distribution Contract with Artes Medical for ELEVESS(R)